tag:blogger.com,1999:blog-317975062011-04-21T12:58:04.939-07:00restohttp://www.blogger.com/profile/06171858944018221172noreply@blogger.comBlogger11100tag:blogger.com,1999:blog-31797506.post-1154081995289285912006-07-28T03:07:00.000-07:002006-07-28T03:24:14.036-07:00<div id="leftnav"> <br /><br /><span style="font-size:130%;"><a href="http://mesothelioma.com/treatment.htm" class="l1">Mesothelioma Treatment</a> </span><br /></div> <!-- begin content --> <h1> <a class="l2">Mesothelioma Alerts</a></h1> <h3><a href="http://mesothelioma.com/mesothelioma_news_onconase.htm">Onconase Shows Unique Promise In Treating Mesothelioma </a></h3> <p class="byline"><strong>RTT News</strong> June 27, 2006</p> <p>Alfacell Corp. said that according to the research findings published in National Academy of Sciences Journal, the company's anti-cancer drug Onconase might be one of the most effective methods of treatment for mesothelioma and lung cancer caused by asbestos. </p> <h3><a href="http://mesothelioma.com/mesothelioma_celebrex.htm">Arthritis Drug Shows Promising Effects For Mesothelioma Victims</a></h3> <p class="byline"><strong>Interscience.Wiley.com</strong> May 19, 2004</p> <p>Researchers in Italy have discovered that studies involving Pfizer Inc.'s arthritis drug Celebrex have shown promising results in combating the effects of cancerous cell growth related to the asbestos-induced disease mesothelioma.</p> <h3><a href="http://mesothelioma.com/mesothelioma_news_alimta_cisplatin.htm">FDA approves Alimta-Cisplatin Combination for treatment of Asbestos-Related Cancer</a></h3> <p class="byline"><strong>Press Release </strong> February 2, 2004</p> <p>The first and only drug regimen proven to help patients with an asbestos-related cancer live longer was approved today by the U.S. Food and Drug Administration.</p> <h3><a href="http://mesothelioma.com/asbestos_news_10-23-02.htm">Implantable Device May Offer Better Pain Management</a></h3> <p class="byline"><strong>National Cancer Institute </strong> October 23, 2002</p> <p>Patients with advanced cancer who used an implantable drug-delivery device to control their pain had better pain relief, fewer toxic side effects, and better survival than patients who received intensive medical pain management, researchers reported in the October 1, 2002, issue of the Journal of Clinical Oncology.</p> <h3><a href="http://mesothelioma.com/asbestos_news_10-9-02.htm">Experimental Cancer Drug Tarceva</a></h3> <p class="byline"><strong>Reuters</strong> October 9, 2002</p> <p>OSI Pharmaceuticals Inc. is more confident than ever of the potential of its experimental cancer drug Tarceva (erlotinib HCl), even after the failure of a similar drug in a major clinical study this summer, OSI Chairman and CEO Dr. Colin Goddard told investors at the UBS Warburg Global Life Sciences conference here on Wednesday.</p><br /><h3><a href="http://mesothelioma.com/mesothelioma_questions.htm" class="strong">Questions to Ask your Doctor</a></h3> <p>As you deal with your cancer and the process of treatment, you need to have honest, open discussions with your cancer care team. We have listed some questions that you might want to ask in this section.</p> <h3><a href="http://mesothelioma.com/cancer_centers.htm" class="strong">Cancer Centers</a></h3> <p>Top Cancer Centers for mesothelioma <strong>treatment</strong> have been listed alphabetically by state for your convenience. Listings include contact information and Web site links where available.</p> <h3><a href="http://mesothelioma.com/doctors.htm" class="strong">Leading Physicians</a></h3> <p>We have become familiar with medical doctors who specialize in aggressively treating <strong>malignant mesothelioma.</strong> Some of these doctors will review your medical records for free to see if you are a candidate for their mesothelioma treatment protocol.</p><p><br /></p><p><br /></p><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/31797506-115408199528928591?l=mesothelioma1000.blogspot.com' alt='' /></div>restohttp://www.blogger.com/profile/06171858944018221172noreply@blogger.com0